Jul 18, 2023 | Business, Health, Science, US
(Reuters) -U.S. drugmaker Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop up to 10 new potential drugs for areas including internal medicine, oncology, infectious diseases and immunology. Flagship, which...
Jul 17, 2023 | Business, Health, Technology, US
By Chibuike Oguh NEW YORK (Reuters) -Shares of AT&T Inc fell nearly 7% to hit their lowest level in thirty years on Monday, after analysts downgraded the stock following a news report that the telecommunications giant left toxic lead cables buried across the U.S....
Jul 17, 2023 | Business, Europe, Health, Top News, UK, US
(Reuters) -The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi and partner AstraZeneca’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers. The therapy, branded Beyfortus, was approved for...
Jul 9, 2023 | Business, Economy, Health, US
By David Randall NEW YORK (Reuters) -As second-quarter earnings approach, investors are looking at beaten-down sectors which might gain ground regardless of whether the U.S. economy falls into recession this year. While the benchmark S&P 500 has gained nearly 15%...
Jul 7, 2023 | Asia, Business, Economy, Entertainment and Lifestyle, Europe, Health, Oddly Enough, Science, Technology, Top News
By Emma Farge GENEVA (Reuters) -Robots presented at an AI forum said on Friday they expected to increase in number and help solve global problems, and would not steal humans’ jobs or rebel against us. But, in the world’s first human-robot press conference,...
Jul 1, 2023 | Asia, Business, Economy, Europe, Health, US
(Reuters) – Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie Inc’s big selling arthritis treatment Humira, adding to U.S. competition for the drug that started in January. The Novartis-owned company said its drug,...
